As quoted in the press release:
Through this acquisition, Alternate Health will be positioned to be a major player in the Florida healthcare market, which is the third most populous state and holds the largest proportion of elderly residents in America. Alternate Health plans to leverage the decades of research, therapeutics, and expertise of the Neubauer Center to expand novel care delivery models and to perform clinical trials.
“Following Florida’s vote last year to legalize medical cannabis, there are countless new opportunities for cannabinoid research and treatment across the state, including the hemp-derived Cannabidiol (CBD) compounds that we are focused on,” said Dr. Jamison Feramisco, CEO, Alternate Health Corp. “The Neubauer Center acquisition strengthens our goal to put patients in charge of their healthcare options, while opening up new revenue streams in untapped markets.”
Source: New feed